Calliditas Thera Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CROSSMARK GLOBAL HOLDINGS, INC. | 11/04/2024 | 16.12 K | $655.00 K | 100.00% | 0.03% |
| ADVISORS PREFERRED, LLC | 10/15/2024 | 2.02 K | $81.51 K | 100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 303 | $12.15 K | 50.00% | 0.00% |
| MISSOURI TRUST & INVESTMENT CO | 11/05/2024 | 35 | $1.40 K | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| COLONIAL TRUST ADVISORS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 0 | $0 | -100.00% | 0.00% |
| OPTIVER HOLDING B.V. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| PLANNING CAPITAL MANAGEMENT CORP | 11/06/2024 | 0 | $0 | -100.00% | 0.00% |
Calliditas Thera institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Calliditas Thera. The most heavily invested institutionals were:
Planning Capital Management Corp: 0
Cutler Group LLC / CA: 0
NEXT Financial Group, Inc: 0
0.03% of Calliditas Thera stock is owned by institutional investors.